Malignant Peritoneal Neoplasm Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02020707Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological CancersTreatment